Of the hundreds of millions of people living with diabetes, most liv. Dexcom wants to make sure they have tools to manage it.

Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...

Dexcom (Nadsaq:DXCM) today announced new insulin delivery integrations and updates on enhanced continuous glucose monitors ...

DexCom received a warning letter from the Food and Drug Administration following inspections of two of its plants.

Investors with a lot of money to spend have taken a bullish stance on DexCom (NASDAQ:DXCM). And retail traders should know. We noticed this today when the positions showed up on publicly available ...

DexCom, Inc. DXCM reported fourth-quarter 2024 ... The broader S&P 500 Index has moved up 10% in the same period. Image Source: Zacks Investment Research Sensor and other revenues (96% of total ...

DexCom said that on Tuesday it received a warning letter from the U.S. FDA following inspections at its facilities in San Diego, Calif., and Mesa, Ariz. related to concerns about manufacturing ...

Dexcom was issued with an FDA warning letter after issues with “manufacturing processes and quality management systems.” ...